<DOC>
	<DOC>NCT00789126</DOC>
	<brief_summary>Study to evaluate the safety and tolerability of single ascending doses and multiple ascending doses of VX-509 administered to healthy male and female subjects</brief_summary>
	<brief_title>Single and Multiple Dose Escalation Study of VX-509 in Healthy Subjects</brief_title>
	<detailed_description>Part A of the study will evaluate the safety and tolerability, PK, and PD of single ascending doses of VX-509. Part B will evaluate the safety and tolerability, PK, and PD of multiple ascending doses of VX-509 administered for 14 days. A total of 72 subjects will be enrolled: 36 subjects in Part A and 36 subjects in Part B.</detailed_description>
	<criteria>Healthy, nonsmoking male or healthy, nonsmoking, nonpregnant female Able to comply with study procedures Male subjects must agree to use 2 highly effective methods of contraception Female subjects must be of documented nonchildbearing potential or must agree to use 2 highly effective methods of contraception No clinically significant abnormal results for physical examination or clinically significant out of range laboratory results History of any significant illness Illness within 5 days before Day 1 Regular treatment with any medications Any type of tobacco or nicotine use History of drug or alcohol abuse or addiction within 2 years before Screening visit Positive tuberculin skin test at Screening Female subjects who are lactating or planning to become pregnant during the study period or within 90 days of last dose of study drug</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>February 2009</verification_date>
</DOC>